Bayer Aktiengesellschaft
BAYZF
$46.28
$2.285.19%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.50% | 3.06% | 1.61% | -3.25% | -2.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.50% | 3.06% | 1.61% | -3.25% | -2.10% |
| Cost of Revenue | -12.56% | -10.02% | 1.39% | -0.19% | 18.26% |
| Gross Profit | 22.12% | 16.70% | 1.79% | -5.27% | -14.20% |
| SG&A Expenses | 13.54% | -2.79% | 4.75% | -6.13% | 9.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 14.39% | -69.09% | -629.32% | 1,474.76% | 49.43% |
| Total Operating Expenses | 5.44% | -21.32% | 1.45% | 3.67% | 156.19% |
| Operating Income | 9.17% | 84.89% | 3.26% | -27.14% | -61.83% |
| Income Before Tax | -665.57% | 71.60% | -363.08% | -31.53% | -128.97% |
| Income Tax Expenses | 369.80% | -40.40% | -250.49% | -13.43% | -150.16% |
| Earnings from Continuing Operations | -1,148.54% | 75.68% | -670.55% | -36.86% | -124.20% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.21% | -138.67% | -18.62% | -142.34% | -38.62% |
| Net Income | -1,124.73% | 75.52% | -517.16% | -37.04% | -124.81% |
| EBIT | 9.17% | 84.89% | 3.26% | -27.14% | -61.83% |
| EBITDA | 32.72% | 115.22% | -30.14% | -19.46% | -60.19% |
| EPS Basic | -1,124.70% | 75.52% | -516.35% | -37.04% | -124.81% |
| Normalized Basic EPS | 12.14% | 71.32% | 34.94% | -31.75% | -54.91% |
| EPS Diluted | -1,124.70% | 75.53% | -516.35% | -37.14% | -124.81% |
| Normalized Diluted EPS | 12.14% | 71.32% | 34.94% | -31.75% | -54.91% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 9.21% | -- | -- | -- | -0.93% |
| Payout Ratio | -- | -5.95% | 0.83% | -- | -- |